OVERVIEW

Virtual Poster Session on Emerging Novel Agents in GBM is organized by prIME Oncology. This CME Conference has been approved for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.

Dates:
Release Date: Jun 14, 2019
Expiration Date: Jun 14, 2020

Target Audience:
This activity is designed for clinicians who are involved in the diagnosis, treatment, and management of patients with glioblastoma (GBM).

Learning Objectives:
After successful completion of this educational activity, participants should be able to:
• Have increased knowledge of key data from the conference regarding emerging novel therapy for the management of GBM
• Have greater competence related to applying key data from the conference to clinical practice, as appropriate for patients with GBM

Additional details will be posted as soon as they are available.